Browsing Artículos (Medicina) by Funding agency "Nanostring Technologies Inc."
Now showing items 1-1 of 1
-
Article
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer
(Taylor and Francis Group, 2015)Purpose: Improved understanding of risk of recurrence (ROR) is needed to reduce cases of recurrence and more effectively ...